Dante Labs: Stripe2be
Jul 08, 2021
Dante Labs has introduced Stripe2be, a whole-genome sequencing platform and business unit dedicated to serving patients with rare diseases. Stripe2be provides personalized reports, generated with the help of artificial intelligence embedded in Dante Labs' Immensa genomic interpretation software, based on the firm's proprietary whole-genome sequencing tests. The new Stripe2be website sells test kits directly to the public.